Barbra Keck
Director of Finance/CFO at SMARTKEM, INC.
Net worth: 1 125 $ as of 31/03/2024
Profile
Barbra C.
Keck is currently the Director at SmartKem Ltd.
and the Chief Financial Officer at SmartKem, Inc. She previously held positions such as Director-Teacher Programs at Muse Machine, Audit Assistant & Member-Auditing Practice at Deloitte & Touche LLP, Manager-Arts Series at the University of Dayton, General Manager at Bach Society of Dayton, Inc., Manager-Donor Relations & Communications at Young Audiences New York, and Dean at Zicklin School of Business.
She also served as the Chief Financial Officer at Deverra Therapeutics, Inc. and Chief Financial & Accounting Officer, Secretary at Delcath Systems, Inc. Ms. Keck obtained an undergraduate degree from the University of Dayton and an MBA from Baruch College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SMARTKEM, INC.
0.01% | 31/01/2024 | 100 ( 0.01% ) | 1 125 $ | 31/03/2024 |
Barbra Keck active positions
| Companies | Position | Start |
|---|---|---|
| SMARTKEM, INC. | Director of Finance/CFO | 14/12/2022 |
SmartKem Ltd.
 SmartKem Ltd. Industrial SpecialtiesProcess Industries SmartKem Ltd. engages in the design, development, industrialization, and technology transfer of solution-deposited organic semiconductors for transistor backplanes. The company was founded by Steve Paul Kelly in 2009 and is headquartered in St. Asaph, the United Kingdom. | Director/Board Member | - |
Former positions of Barbra Keck
| Companies | Position | End |
|---|---|---|
Deverra Therapeutics, Inc.
 Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Director of Finance/CFO | 31/05/2020 |
| DELCATH SYSTEMS, INC. | Director of Finance/CFO | 01/05/2020 |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | 04/12/2008 |
| Zicklin School of Business | Corporate Officer/Principal | 01/08/2008 |
| Young Audiences New York | Public Communications Contact | 01/05/2006 |
Training of Barbra Keck
| University of Dayton | Undergraduate Degree |
| Baruch College | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DELCATH SYSTEMS, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
Bach Society of Dayton, Inc.
 Bach Society of Dayton, Inc. Miscellaneous Commercial ServicesCommercial Services Bach Society of Dayton, Inc. performs and conducts singing shows. The company was founded in 2002 and is headquartered in Dayton, OH. | Commercial Services |
SmartKem Ltd.
SmartKem Ltd. Industrial SpecialtiesProcess Industries SmartKem Ltd. engages in the design, development, industrialization, and technology transfer of solution-deposited organic semiconductors for transistor backplanes. The company was founded by Steve Paul Kelly in 2009 and is headquartered in St. Asaph, the United Kingdom. | Process Industries |
| Young Audiences New York | |
| Muse Machine | |
| SmartKem, Inc. | |
Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Barbra Keck
